Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Carcinoma, Ductal, Pancreatic

1-methyl-3-isobutylxanthine has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burdyga, A1
Conant, A1
Haynes, L1
Zhang, J1
Jalink, K1
Sutton, R1
Neoptolemos, J1
Costello, E1
Tepikin, A1
Zimmerman, NP1
Roy, I1
Hauser, AD1
Wilson, JM1
Williams, CL1
Dwinell, MB1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Carcinoma, Ductal, Pancreatic

ArticleYear
cAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: effects of PKA and EPAC.
    Biochimica et biophysica acta, 2013, Volume: 1833, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Mo

2013
Cyclic AMP regulates the migration and invasion potential of human pancreatic cancer cells.
    Molecular carcinogenesis, 2015, Volume: 54, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Amides; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell

2015